Scinai Immunotherapeutics (SCNI) Share-based Compensation (QoQ) (2020 - 2026)

Scinai Immunotherapeutics (SCNI) Share-based Compensation (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Scinai Immunotherapeutics 352,860.00 -3.11 Bn -1.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.78%
Dec 31, 2024 226.90%
Sep 30, 2024 2.11%
Jun 30, 2024 -25.65%
Mar 31, 2024 -57.84%
Dec 31, 2023 93.59%
Sep 30, 2023 17.00%
Jun 30, 2023 -20.63%
Mar 31, 2023 -36.68%
Dec 31, 2022 19.16%
Sep 30, 2022 212.15%
Jun 30, 2022 -77.94%
Mar 31, 2022 -33.29%
Dec 31, 2021 -71.23%
Sep 30, 2021 -1.86%
Jun 30, 2021 489.24%
Mar 31, 2021 -67.44%
Dec 31, 2020 -70.83%
Sep 30, 2020 38.30%